Myocardial proteases and cardiac remodeling

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Biochemistry

Background:

• Cardiac hypertrophy (CH) is a major cause of mortality, characterized by cardiomyocyte enlargement, fibrosis, and apoptosis.
• Existing cardiovascular research highlights the need for understanding CH signaling pathways to find new therapeutic strategies.
• Extracellular matrix (ECM) remodeling is a key feature of CH.

Purpose of the Study:

• To review the critical roles of cysteine cathepsins and matrix metalloproteinases (MMPs) in the context of cardiac remodeling.
• To identify potential therapeutic targets within these protease families for managing cardiac hypertrophy.

Main Methods:

• Literature review focusing on studies investigating cysteine cathepsins and MMPs in cardiac hypertrophy and remodeling.
• Analysis of existing research on the involvement of these proteases in the pathological changes of the heart.

Main Results:

• Cysteine cathepsins and MMPs are significantly implicated in the ECM remodeling observed in cardiac hypertrophy.
• These proteases contribute to the structural and functional changes characteristic of a hypertrophied heart.

Conclusions:

• Cysteine cathepsins and MMPs represent promising targets for therapeutic intervention in cardiac hypertrophy.
• Further research into the specific mechanisms of these proteases in cardiac remodeling is warranted.